Showing results (71-80 of 604) with videos related to

Sort By:
Pageof 61
Pharmacoeconomics - Open|August 22, 2023
Public Health Impact and Cost-Effectiveness of Empagliflozin (JARDIANCE®) in the Treatment of Patients with Heart Failure with Preserved Ejection Fraction in France, Based on the EMPEROR-Preserved Clinical TrialLaurent Fauchier, Nicolas Lamblin, Jean Tardu, et al.
Pharmacoeconomics - Open|September 21, 2023
Onasemnogene Abeparvovec for Treating Pre-symptomatic Spinal Muscular Atrophy: An External Assessment Group Perspective of the Partial Review of NICE Highly Specialised Technology Evaluation 15Marty Chaplin, Rebecca Bresnahan, Nigel Fleeman, et al.
Pharmacoeconomics - Open|December 4, 2018
Uterotonic Drugs for the Prevention of Postpartum Haemorrhage: A Cost-Effectiveness AnalysisKaren Pickering, Ioannis D Gallos, Helen Williams, et al.
Pharmacoeconomics - Open|February 6, 2019
Evolution of Average European Medicine Prices: Implications for the Methodology of External Price ReferencingSabine Vogler, Peter Schneider, Nina Zimmermann
Pharmacoeconomics - Open|September 8, 2020
Healthcare Utilization and Cost Burden of Porphyria in Commercially Insured Adults in the United StatesMohamed I Elsaid, You Li, Carolyn Catalano, et al.
Pharmacoeconomics - Open|September 17, 2020
Costs and Extra Length of Stay because of Neonatal Bloodstream Infection at a Teaching Hospital in GhanaAma Pokuaa Fenny, Evans Otieku, Kwaku Appiah-Korang Labi, et al.
Pharmacoeconomics - Open|March 28, 2020
Observational Cost-Effectiveness Analysis Using Routine Data: Admission and Discharge Care Bundles for Patients with Chronic Obstructive Pulmonary DiseasePadraig Dixon, William Hollingworth, Jonathan Benger, et al.
Pharmacoeconomics - Open|March 29, 2020
Estimation of the Incremental Cumulative Cost of HIV Compared with a Non-HIV PopulationJoshua P Cohen, Anne Beaubrun, Yao Ding, et al.
Pharmacoeconomics - Open|October 14, 2020
Productivity Loss and Associated Costs Among Employed Patients Receiving Disease-Modifying Treatment for Multiple SclerosisMachaon Bonafede, Rina Mehta, Gilwan Kim, et al.
Pharmacoeconomics - Open|February 15, 2018
Communal Sharing and the Provision of Low-Volume High-Cost Health Services: Results of a SurveyJeff Richardson, Angelo Iezzi, Gang Chen, et al.
Pageof 61